Helix Partners Management increased its stake in Core Scientific by 350,000 shares in the fourth quarter, with an estimated trade value of $6.10 million. Despite this buy, the reported value of the Core Scientific position fell by $12.65 million due to additional purchases and stock price changes. Post-trade, Helix Partners Management LP held 5,600,000 Core Scientific shares valued at $81.54 million, making up 27.41% of the fund’s reportable AUM.

Core Scientific, a leading provider of digital asset mining and blockchain infrastructure services, saw high-density colocation revenue rise to $15.0 million in the third quarter of 2025. The company reported $81.1 million in revenue, with a net loss of $146.7 million, attributed to noncash fair value adjustments. Core Scientific has liquidity of $694.8 million, including $453.4 million in cash and $241.4 million in bitcoin. The company is focusing on high-density colocation tied to AI workloads, with capital expenditures funded by CoreWeave.

Investors should consider the significant portfolio concentration in Core Scientific, which accounts for 27.4% of Helix Partners Management LP’s AUM. The company’s pivot towards high-density colocation and infrastructure solutions is a key focus for long-term investors. Before buying stock in Core Scientific, investors may want to explore other investment opportunities identified by the Motley Fool Stock Advisor analyst team, which has a track record of identifying top-performing stocks.

Read more at Nasdaq: Core Scientific Stock Up 45% This Past Year: Fund Lifts Stake Despite Volatility and $147 Million Q3 Loss